Entheon Biomedical Corp. (CSE: ENBI)
Interview with Timothy Ko, CEO […]
Interview with Timothy Ko, CEO […]
CEO Jim Joyce discusses Sigyn’s recent news over the last couple months which includes a pilot study to address inflammatory CytoVesicles. […]
Dr. Alen Davidoff provided an update on his previous interview from August 2020. Xortx just announced a recent grant on their European patent as well as other activity in the market. The company is hoping to start on their phase III trial on their autosomal dominant polycystic kidney disease program in the next quarter as well as up-list to a higher-tiered US exchange. […]
ABOUT: CanaQuest Medical Corp is a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade). The Company is the industry partner for research and product development with Dr. Steven Laviolette, […]
Interview with Adrian Smith, CEO […]
Xortx CEO Dr. Allen Davidoff took time to update investors on the company’s accomplishments over the last several months. XRX just announced a partnership with Mount Sinai’s Icahn school of medicine for a US based COVID-19 clinical trial for acute kidney injury associated with the virus. […]
WSA caught up with VIT to discuss progress since their previous interview from September 2019. The company has since uplisted to the TSX and reached commercial production on their Eagle Gold Mine in the Yukon, Canada. They have also completed a 23 million public offering and seen the stock nearly triple in the last 3 months. […]
Pro-Dex, Inc. specializes in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic and maxocranial facial markets. […]
Interview with Dwight Egan, CEO […]
“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com